English
简体中文
Total: £ 56.28
Published Date: 2026-03-02 | Pages: 107 | Tables: 102 | Medical Care
The global Blastic Plasmacytoid Dendritic Cell Neoplasm market was valued at US$ 156 million in 2025 and is anticipated to reach US$ 257 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
This growth is attributed to the rising global incidence of lung cancer, development of innovative treatment options, and increased awareness and screening programs.
The North American market for Blastic Plasmacytoid Dendritic Cell Neoplasm is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Blastic Plasmacytoid Dendritic Cell Neoplasm is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Blastic Plasmacytoid Dendritic Cell Neoplasm in Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Blastic Plasmacytoid Dendritic Cell Neoplasm include AbbVie Inc., ImmunoGen, Inc., Mustang Bio, Genentech, Inc., Stemline Therapeutics, Inc., Jazz Pharmaceuticals, Inc., Cellex Patient Treatment GmbH, Xencor, Resverlogix, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Blastic Plasmacytoid Dendritic Cell Neoplasm market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blastic Plasmacytoid Dendritic Cell Neoplasm. The Blastic Plasmacytoid Dendritic Cell Neoplasm market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blastic Plasmacytoid Dendritic Cell Neoplasm market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blastic Plasmacytoid Dendritic Cell Neoplasm manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
AbbVie Inc.
ImmunoGen, Inc.
Mustang Bio
Genentech, Inc.
Stemline Therapeutics, Inc.
Jazz Pharmaceuticals, Inc.
Cellex Patient Treatment GmbH
Xencor
Resverlogix
Segment by Type
Chemotherapy
Immunotherapy
Stem Cell Transplantation
Targeted Therapy
Other
Segment by Application
Hospitals
Specialty Clinics
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Blastic Plasmacytoid Dendritic Cell Neoplasm companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Stem Cell Transplantation
1.2.5 Targeted Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Perspective (2021–2032)
2.2 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Growth Trends by Region
2.2.1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Blastic Plasmacytoid Dendritic Cell Neoplasm Historic Market Size by Region (2021–2026)
2.2.3 Blastic Plasmacytoid Dendritic Cell Neoplasm Forecasted Market Size by Region (2027–2032)
2.3 Blastic Plasmacytoid Dendritic Cell Neoplasm Market Dynamics
2.3.1 Blastic Plasmacytoid Dendritic Cell Neoplasm Industry Trends
2.3.2 Blastic Plasmacytoid Dendritic Cell Neoplasm Market Drivers
2.3.3 Blastic Plasmacytoid Dendritic Cell Neoplasm Market Challenges
2.3.4 Blastic Plasmacytoid Dendritic Cell Neoplasm Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blastic Plasmacytoid Dendritic Cell Neoplasm Players by Revenue
3.1.1 Global Top Blastic Plasmacytoid Dendritic Cell Neoplasm Players by Revenue (2021–2026)
3.1.2 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue Market Share by Players (2021–2026)
3.2 Global Top Blastic Plasmacytoid Dendritic Cell Neoplasm Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue
3.4 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Concentration Ratio
3.4.1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue in 2025
3.5 Global Key Players of Blastic Plasmacytoid Dendritic Cell Neoplasm Head Offices and Areas Served
3.6 Global Key Players of Blastic Plasmacytoid Dendritic Cell Neoplasm, Products and Applications
3.7 Global Key Players of Blastic Plasmacytoid Dendritic Cell Neoplasm, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Blastic Plasmacytoid Dendritic Cell Neoplasm Breakdown Data by Type
4.1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Historic Market Size by Type (2021–2026)
4.2 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Forecasted Market Size by Type (2027–2032)
5 Blastic Plasmacytoid Dendritic Cell Neoplasm Breakdown Data by Application
5.1 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Historic Market Size by Application (2021–2026)
5.2 Global Blastic Plasmacytoid Dendritic Cell Neoplasm Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size (2021–2032)
6.2 North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (2021–2026)
6.4 North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size (2021–2032)
7.2 Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (2021–2026)
7.4 Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size (2021–2032)
8.2 Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Region (2021–2026)
8.4 Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size (2021–2032)
9.2 Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (2021–2026)
9.4 Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size (2021–2032)
10.2 Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (2021–2026)
10.4 Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.1.4 AbbVie Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.1.5 AbbVie Inc. Recent Development
11.2 ImmunoGen, Inc.
11.2.1 ImmunoGen, Inc. Company Details
11.2.2 ImmunoGen, Inc. Business Overview
11.2.3 ImmunoGen, Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.2.4 ImmunoGen, Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.2.5 ImmunoGen, Inc. Recent Development
11.3 Mustang Bio
11.3.1 Mustang Bio Company Details
11.3.2 Mustang Bio Business Overview
11.3.3 Mustang Bio Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.3.4 Mustang Bio Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.3.5 Mustang Bio Recent Development
11.4 Genentech, Inc.
11.4.1 Genentech, Inc. Company Details
11.4.2 Genentech, Inc. Business Overview
11.4.3 Genentech, Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.4.4 Genentech, Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.4.5 Genentech, Inc. Recent Development
11.5 Stemline Therapeutics, Inc.
11.5.1 Stemline Therapeutics, Inc. Company Details
11.5.2 Stemline Therapeutics, Inc. Business Overview
11.5.3 Stemline Therapeutics, Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.5.4 Stemline Therapeutics, Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.5.5 Stemline Therapeutics, Inc. Recent Development
11.6 Jazz Pharmaceuticals, Inc.
11.6.1 Jazz Pharmaceuticals, Inc. Company Details
11.6.2 Jazz Pharmaceuticals, Inc. Business Overview
11.6.3 Jazz Pharmaceuticals, Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.6.4 Jazz Pharmaceuticals, Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.6.5 Jazz Pharmaceuticals, Inc. Recent Development
11.7 Cellex Patient Treatment GmbH
11.7.1 Cellex Patient Treatment GmbH Company Details
11.7.2 Cellex Patient Treatment GmbH Business Overview
11.7.3 Cellex Patient Treatment GmbH Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.7.4 Cellex Patient Treatment GmbH Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.7.5 Cellex Patient Treatment GmbH Recent Development
11.8 Xencor
11.8.1 Xencor Company Details
11.8.2 Xencor Business Overview
11.8.3 Xencor Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.8.4 Xencor Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.8.5 Xencor Recent Development
11.9 Resverlogix
11.9.1 Resverlogix Company Details
11.9.2 Resverlogix Business Overview
11.9.3 Resverlogix Blastic Plasmacytoid Dendritic Cell Neoplasm Introduction
11.9.4 Resverlogix Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
11.9.5 Resverlogix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Stem Cell Transplantation
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Other
Table 7. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Region (US$ Million), 2021–2026
Table 10. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Region (2021–2026)
Table 11. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Region (2027–2032)
Table 13. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Trends
Table 14. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Drivers
Table 15. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Challenges
Table 16. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Restraints
Table 17. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue by Players (US$ Million), 2021–2026
Table 18. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Players (2021–2026)
Table 19. Global Top Blastic Plasmacytoid Dendritic Cell Neoplasm Players by Tier (Tier 1, Tier 2, and Tier 3), based on Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue, 2025
Table 20. Ranking of Global Top Blastic Plasmacytoid Dendritic Cell Neoplasm Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Blastic Plasmacytoid Dendritic Cell Neoplasm, Headquarters and Area Served
Table 23. Global Key Players of Blastic Plasmacytoid Dendritic Cell Neoplasm, Products and Applications
Table 24. Global Key Players of Blastic Plasmacytoid Dendritic Cell Neoplasm, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Type (US$ Million), 2021–2026
Table 27. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue Market Share by Type (2021–2026)
Table 28. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue Market Share by Type (2027–2032)
Table 30. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Application (US$ Million), 2021–2026
Table 31. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue Market Share by Application (2021–2026)
Table 32. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue Market Share by Application (2027–2032)
Table 34. North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (US$ Million), 2021–2026
Table 36. North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Country (US$ Million), 2027–2032
Table 49. AbbVie Inc. Company Details
Table 50. AbbVie Inc. Business Overview
Table 51. AbbVie Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 52. AbbVie Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 53. AbbVie Inc. Recent Development
Table 54. ImmunoGen, Inc. Company Details
Table 55. ImmunoGen, Inc. Business Overview
Table 56. ImmunoGen, Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 57. ImmunoGen, Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 58. ImmunoGen, Inc. Recent Development
Table 59. Mustang Bio Company Details
Table 60. Mustang Bio Business Overview
Table 61. Mustang Bio Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 62. Mustang Bio Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 63. Mustang Bio Recent Development
Table 64. Genentech, Inc. Company Details
Table 65. Genentech, Inc. Business Overview
Table 66. Genentech, Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 67. Genentech, Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 68. Genentech, Inc. Recent Development
Table 69. Stemline Therapeutics, Inc. Company Details
Table 70. Stemline Therapeutics, Inc. Business Overview
Table 71. Stemline Therapeutics, Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 72. Stemline Therapeutics, Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 73. Stemline Therapeutics, Inc. Recent Development
Table 74. Jazz Pharmaceuticals, Inc. Company Details
Table 75. Jazz Pharmaceuticals, Inc. Business Overview
Table 76. Jazz Pharmaceuticals, Inc. Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 77. Jazz Pharmaceuticals, Inc. Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 78. Jazz Pharmaceuticals, Inc. Recent Development
Table 79. Cellex Patient Treatment GmbH Company Details
Table 80. Cellex Patient Treatment GmbH Business Overview
Table 81. Cellex Patient Treatment GmbH Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 82. Cellex Patient Treatment GmbH Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 83. Cellex Patient Treatment GmbH Recent Development
Table 84. Xencor Company Details
Table 85. Xencor Business Overview
Table 86. Xencor Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 87. Xencor Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 88. Xencor Recent Development
Table 89. Resverlogix Company Details
Table 90. Resverlogix Business Overview
Table 91. Resverlogix Blastic Plasmacytoid Dendritic Cell Neoplasm Product
Table 92. Resverlogix Revenue in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (US$ Million), 2021–2026
Table 93. Resverlogix Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Blastic Plasmacytoid Dendritic Cell Neoplasm Picture
Figure 2. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Type: 2025 vs 2032
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Stem Cell Transplantation Features
Figure 7. Targeted Therapy Features
Figure 8. Other Features
Figure 9. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Application: 2025 vs 2032
Figure 11. Hospitals Case Studies
Figure 12. Specialty Clinics Case Studies
Figure 13. Other Case Studies
Figure 14. Blastic Plasmacytoid Dendritic Cell Neoplasm Report Years Considered
Figure 15. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Region: 2025 vs 2032
Figure 18. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Players in 2025
Figure 19. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Blastic Plasmacytoid Dendritic Cell Neoplasm Revenue in 2025
Figure 21. North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Country (2021–2032)
Figure 23. United States Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Country (2021–2032)
Figure 27. Germany Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Region (2021–2032)
Figure 35. China Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Country (2021–2032)
Figure 43. Mexico Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Blastic Plasmacytoid Dendritic Cell Neoplasm Market Share by Country (2021–2032)
Figure 47. Israel Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. AbbVie Inc. Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 51. ImmunoGen, Inc. Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 52. Mustang Bio Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 53. Genentech, Inc. Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 54. Stemline Therapeutics, Inc. Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 55. Jazz Pharmaceuticals, Inc. Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 56. Cellex Patient Treatment GmbH Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 57. Xencor Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 58. Resverlogix Revenue Growth Rate in Blastic Plasmacytoid Dendritic Cell Neoplasm Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
